Marc Wiles

Marc Wiles has over 20 years of experience in regulatory affairs and pharmaceutical development. Currently, they serve as the Senior Vice President of Regulatory Affairs at Aptose Biosciences, Inc. Marc previously held the position of Vice President of Regulatory Affairs at Agenus.

Prior to their roles at Aptose Biosciences, Inc. and Agenus, Marc worked at Baxter International Inc. as the Senior Director of Global Regulatory Lead for Pharmaceuticals. In this role, they collaborated with various global business units and R&D organizations to develop complex molecules and biosimilars.

Before joining Baxter, Marc was the Vice President of Scientific and Regulatory Affairs at Camargo Pharmaceutical Services. Marc provided comprehensive drug development services and strategic guidance for product development opportunities.

Marc also has experience as a General Manager at NDA Group AB, Director and General Manager at ERA Consulting (UK) Ltd., and Senior Vice President of Operations at ProImmune, Ltd.

Earlier in their career, Marc held leadership roles at Novexel and Shire HGT, where they were responsible for nonclinical development and toxicology-related activities.

Overall, Marc Wiles has a wealth of experience in regulatory affairs, drug development, and strategic planning in the pharmaceutical industry.

Marc Wiles obtained a Bachelor of Arts degree in Biology and Chemistry from Macalester College, where they studied from 1982 to 1986. Following their undergraduate studies, they pursued a PhD at Boston University in the field of Cell Biology and Microvascular Physiology, attaining their doctoral degree in 1991.